This is the authors' abstract. We don't add key points for this paper.
These results provide a missing link between tumor immunity and disease outcome in ER+ disease by examining tumor spatial architecture. The association between spatial scores and late recurrence suggests a lasting memory of protumor immunity that may impact disease progression and evolution of endocrine treatment resistance, which may be exploited for therapeutic advances.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Heindl et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: